The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...